Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

274,123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma.
Liu JX, Liu X, Yang Y, Liu WP, Wang Y, He X, Zhang LL, Qu BL, Qian LT, Hou XR, Qiao XY, Wang H, Li GF, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Zhang HL, Su H, Zhang YJ, Zhu J, Qi SN, Li YX, Song YQ. Liu JX, et al. Among authors: wang h, wang y. Cancer Rep (Hoboken). 2023 May;6(5):e1800. doi: 10.1002/cnr2.1800. Epub 2023 Mar 15. Cancer Rep (Hoboken). 2023. PMID: 36919649 Free PMC article.
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database.
Zheng X, Qu BL, Liu X, Zhong QZ, Qian LT, Yang Y, Hou XR, Qiao XY, Wang H, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Zhang HL, Zhang XM, Su H, Song YQ, Zhu J, Zhang YJ, Huang HQ, Wang Y, Chen F, Yin L, He X, Zhang LL, Li YX, Qi SN. Zheng X, et al. Among authors: wang h, wang y. EJHaem. 2022 Nov 25;4(1):78-89. doi: 10.1002/jha2.613. eCollection 2023 Feb. EJHaem. 2022. PMID: 36819187 Free PMC article.
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database.
Liu X, Zhang LL, Qu BL, Zhong QZ, Qian LT, Yang Y, Hou XR, Qiao XY, Wang H, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Zhang HL, Zhang XM, Su H, Song YQ, Zhu J, Zhang YJ, Huang HQ, Wang Y, Chen F, Yin L, He X, Cai S, Li YX, Qi SN. Liu X, et al. Among authors: wang h, wang y. Haematologica. 2023 Sep 1;108(9):2467-2475. doi: 10.3324/haematol.2022.281847. Haematologica. 2023. PMID: 36951150 Free PMC article.
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study.
Li JY, Hou XR, Chen SY, Liu X, Zhong QZ, Qian LT, Qiao XY, Wang H, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Zhang HL, Zhang XM, Su H, Song YQ, Zhu J, Zhang YJ, Huang HQ, Wang Y, He X, Zhang LL, Qu BL, Yang Y, Hu C, Deng M, Wang SL, Qi SN, Li YX. Li JY, et al. Among authors: wang h, wang y, wang sl. Ann Hematol. 2023 Sep;102(9):2459-2469. doi: 10.1007/s00277-023-05311-5. Epub 2023 Jun 12. Ann Hematol. 2023. PMID: 37306711 Free PMC article.
[Minutes of the 2022 China Rhinology Annual Meeting].
Zhang T, Jin Y, Wang HG, You MA, Huang X, Zhou FW, Wang ZJ, Li JY, Wang Y, Zhu L, Zeng MT, Yuan FY, Li YS, Ruan GX, Yu GD. Zhang T, et al. Among authors: wang zj, wang hg, wang y. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Dec 7;57(12):1516-1519. doi: 10.3760/cma.j.cn115330-20221111-00680. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022. PMID: 36707962 Chinese. No abstract available.
[A comparative clinical study of modified IA "3+4" regimen and intermediate-dose cytarabine regimen in the consolidation treatment of low-risk acute myeloid leukemia].
Liu XH, Jia JS, Wang J, Gong LZ, Tang FF, Yu WJ, Zhu XL, Wang Y, Jiang Q, Chang YJ, Zhao XS, Ruan GR, Qin YZ, Huang XJ, Jiang H. Liu XH, et al. Among authors: wang j, wang y. Zhonghua Xue Ye Xue Za Zhi. 2022 Jul 14;43(7):594-597. doi: 10.3760/cma.j.issn.0253-2727.2022.07.011. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 36709138 Free PMC article. Chinese. No abstract available.
Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical trial in healthy Chinese adults.
Jin Z, Wu J, Wang Y, Huang T, Zhao K, Liu J, Wang H, Zhu T, Gou J, Huang H, Wu X, Yin H, Song J, Li R, Zhang J, Li L, Chen J, Li X, Zhang M, Li J, Hou M, Song Y, Wang B, Gao Q, Wu L, Kong Y, Dong R. Jin Z, et al. Among authors: wang h, wang y, wang b. J Infect. 2023 Dec;87(6):556-570. doi: 10.1016/j.jinf.2023.10.012. Epub 2023 Oct 28. J Infect. 2023. PMID: 37898410 Clinical Trial.
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.
Sawhney JP, Kothiwale VA, Bisne V, Durgaprasad R, Jadhav P, Chopda M, Vanajakshamma V, Meena R, Vijayaraghavan G, Chawla K, Allu J, Pieper KS, John Camm A, Kakkar AK; GARFIELD-AF Investigators. Sawhney JP, et al. Indian Heart J. 2018 Nov-Dec;70(6):828-835. doi: 10.1016/j.ihj.2018.09.001. Epub 2018 Sep 12. Indian Heart J. 2018. PMID: 30580852 Free PMC article. Clinical Trial.
Effect of an Herbal-Based Injection on 28-Day Mortality in Patients With Sepsis: The EXIT-SEP Randomized Clinical Trial.
Liu S, Yao C, Xie J, Liu H, Wang H, Lin Z, Qin B, Wang D, Lu W, Ma X, Liu Y, Liu L, Zhang C, Xu L, Zheng R, Zhou F, Liu Z, Zhang G, Zhou L, Liu J, Fei A, Zhang G, Zhu Y, Qian K, Wang R, Liang Y, Duan M, Wu D, Sun R, Wang Y, Zhang X, Cao Q, Yang M, Jin M, Song Y, Huang L, Zhou F, Chen D, Liang Q, Qian C, Tang Z, Zhang Z, Feng Q, Peng Z, Sun R, Song Z, Sun Y, Chai Y, Zhou L, Cheng C, Li L, Yan X, Zhang J, Huang Y, Guo F, Li C, Yang Y, Shang H, Qiu H; EXIT-SEP Investigators. Liu S, et al. Among authors: wang h, wang y, wang d, wang r. JAMA Intern Med. 2023 Jul 1;183(7):647-655. doi: 10.1001/jamainternmed.2023.0780. JAMA Intern Med. 2023. PMID: 37126332 Free PMC article.
274,123 results
You have reached the last available page of results. Please see the User Guide for more information.